←Back to Expert Scholars
Translational Medicine / 转化医学Milestone Pediatric Oncology, Chemotherapy Pioneer
Sidney Farber
MD
🏢Boston Children's Hospital (Dana-Farber)🌐USA
Founder Modern Chemotherapy (historical)
75
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Sidney Farber (1903-1973) pioneered the use of aminopterin to induce the first remissions in childhood acute lymphoblastic leukemia in 1947-1948, marking the birth of modern cancer chemotherapy. The Dana-Farber Cancer Institute bears his name.
Share:
🧪Research Fields 研究领域
pediatric leukemia
aminopterin/methotrexate
first chemotherapy remissions
Dana-Farber founder
chemotherapy pioneer
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Sidney Farber 的研究动态
Follow Sidney Farber's research updates
留下邮箱，当我们发布与 Sidney Farber（Boston Children's Hospital (Dana-Farber)）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment